The treatment, called Paxlovid, is likely to work against Omicron and could be available in the United States before the end of the year.
https://siii-clinical.com/wp-content/uploads/2021/09/Untitled-1.png00https://siii-clinical.com/wp-content/uploads/2021/09/Untitled-1.png2021-12-14 23:55:132021-12-14 23:55:13Pfizer’s Covid Pill Works Well, Company Confirms in Final Analysis
From research laboratories to clinical settings, SIII integrates the technologies, resources, and expertise our customers need to rise to the next opportunity. SIII is dedicated to exploring and researching the processes and scientific mechanisms underlying the world we live in.